You have 9 free searches left this month | for more free features.

amifostine

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oral Mucositis, Stomatitis Trial (Amifostine)

Withdrawn
  • Oral Mucositis
  • Stomatitis
  • Amifostine
  • (no location specified)
Nov 9, 2021

Solid Tumors, Brain Tumors Trial in Cincinnati (Amifostine)

Terminated
  • Solid Tumors
  • Brain Tumors
  • Amifostine
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 29, 2021

Lung Cancer Trial in Houston (Cisplatin, Amifostine)

Active, not recruiting
  • Lung Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 29, 2022

Locally Advanced Rectal Cancer Trial in Shanghai (Radiation, Capecitabine, Irinotecan)

Unknown status
  • Locally Advanced Rectal Cancer
  • Radiation
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 19, 2019

Cancer of Head and Neck, Head Cancer, Head Neck Cancer Trial in Birmingham (Cisplatin, Docetaxel, Radiotherapy)

Completed
  • Cancer of Head and Neck
  • +4 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 2, 2019

Trigeminal Neuralgia Trial in Stanford (Amifostine, CyberKnife stereotactic radiosurgery)

Terminated
  • Trigeminal Neuralgia
  • Amifostine
  • CyberKnife stereotactic radiosurgery
  • Stanford, California
    Stanford University School of Medicine
Feb 16, 2017

Head Neck Cancer Trial in Baltimore (Amifostine, Carboplatin, Taxol)

Completed
  • Head and Neck Cancer
  • Amifostine
  • +3 more
  • Baltimore, Maryland
    University of Maryland
Dec 5, 2016

Malignant Pleural Mesothelioma Trial in Boston (Extrapleural pneumonectomy (EPP), Cisplatin, gemcitabine)

Completed
  • Malignant Pleural Mesothelioma
  • Extrapleural pneumonectomy (EPP)
  • +5 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 19, 2017

Bladder Cancer, Brain and CNS Tumors, Carcinoma of Unknown Primary Trial in Boston (biological, drug, procedure)

Completed
  • Bladder Cancer
  • +10 more
  • filgrastim
  • +5 more
  • Boston, Massachusetts
  • +2 more
Jan 19, 2017

Chemotherapeutic Agent Toxicity, Head Neck Cancer, Mucositis Trial in United States (Amifostine, Carboplatin, Paclitaxel)

Completed
  • Chemotherapeutic Agent Toxicity
  • +4 more
  • Amifostine
  • +3 more
  • Sanford, Maine
  • +8 more
Jan 3, 2017

Rectal Cancer Trial in Beijing (Amifostine)

Unknown status
  • Rectal Cancer
  • Amifostine
  • Beijing, Beijing, China
    Radiation Oncology Depratment, Cancer Hospital, CAMS
Aug 14, 2013

Cervical Cancer Trial in Birmingham (Radiation Therapy, Cisplatin, Amifostine)

Withdrawn
  • Cervical Cancer
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 23, 2013

Lymphoma Trial in Los Angeles (Amifostine, DHAP)

Completed
  • Lymphoma
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Oct 3, 2012

Breast Cancer, Lung Cancer, Neurotoxicity Trial in United States (Amifostine)

Completed
  • Breast Cancer
  • +5 more
  • Amifostine
  • Decatur, Illinois
  • +14 more
Oct 16, 2012

Head Neck Cancer Trial in Houston (Amifostine, Intensity- Modulated Radiation Therapy)

Terminated
  • Head and Neck Cancer
  • Amifostine
  • Intensity- Modulated Radiation Therapy
  • Houston, Texas
    U.T. M.D. Anderson Cancer Center
Jul 31, 2012

Colorectal Cancer Trial in Cincinnati (Amifostine)

Terminated
  • Colorectal Cancer
  • Amifostine
  • Cincinnati, Ohio
    University of Cincinnati
Mar 22, 2010

Lymphoma, Hodgkin's Disease, Non-Hodgkin's Lymphoma Trial in Boston (Amifostine, Radiation Therapy)

Completed
  • Lymphoma
  • +2 more
  • Amifostine
  • Radiation Therapy
  • Boston, Massachusetts
  • +1 more
Oct 30, 2009

Esophagitis, Pneumonitis, Non-Small Cell Lung Carcinoma Trial in United States (Amifostine)

Completed
  • Esophagitis
  • +2 more
  • Amifostine
  • Los Angeles, California
  • +23 more
Aug 20, 2007

Fanconi's Anemia Trial in Boston (amifostine)

Unknown status
  • Fanconi's Anemia
  • amifostine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jun 23, 2005